Alternatives to Altis Labs Nota

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

Our worldwide data-sharing network produces actionable clinical insights from data aimed at enhancing patient outcomes on a global scale. SOPHiA GENETICS is dedicated to shaping the future of AI-enhanced medicine. By integrating various healthcare-omics data types, we are dismantling existing data barriers and creating machine learning models that yield insights capable of aiding healthcare professionals in elevating patient care. The updated interface, along with new features and advanced functionalities, will further expedite precision medicine workflows, bringing us closer to making data-driven healthcare accessible to all. Utilizing the power of AI and machine learning (ML), our cloud-based platform offers a secure and easily accessible space for the standardization, computation, and analysis of digital health data, which generates insights from intricate multimodal data sets that can significantly enhance diagnostic processes, therapy choices, analytical methods, and drug development initiatives. Moreover, our continuous evolution reflects our commitment to innovation in the healthcare sector.

Our platform, designed with regulatory compliance in mind, enhances clinical research by using algorithms to sift through unstructured EMR data to identify life-threatening conditions. We create cutting-edge technologies that broaden access to groundbreaking healthcare solutions through Clinical Trials. Our dedicated team is committed to saving lives by facilitating access to therapeutic innovations that are still being researched. We strongly advocate that every patient should be informed and empowered regarding their potential to engage in clinical trials that could offer significant therapeutic benefits. As a forward-thinking healthcare AI research firm, we have created a computational platform that identifies patients who meet a detailed set of criteria for participation in clinical trials, ensuring that the most suitable candidates are considered for these critical studies. Through our work, we aim to revolutionize the way patients connect with life-changing treatment opportunities.

OM1 leverages artificial intelligence and extensive clinical data to significantly enhance research productivity and clinical decision-making via high-performance predictive models. The OM1 Patient Finder employs advanced AI technology seamlessly integrated with the OM1 Real-World Data Cloud. By merging various aspects of patient journeys from diverse data sources, it effectively identifies individuals most likely to be affected by the target condition. We have developed an intelligent data cloud that allows various healthcare stakeholders to access, analyze, and utilize outcomes data in a manner that is not only more comprehensive but also clinically relevant and precise. This enables rapid, accurate, and cost-effective access to research-grade insights regarding effectiveness, value, and safety. Moreover, it allows for the quantification of outcomes, facilitating the demonstration of value in risk-sharing and outcomes-based payment models. As a result, healthcare providers can make informed decisions grounded in real-world evidence.

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Precision, efficiency, and assurance. The integration of generative AI into the biopharmaceutical industry is here. This technology streamlines the arduous task of gathering, organizing, and analyzing extensive data sets. Achieve essential insights with complete assurance every single time. With our AI-driven platform for data handling and validation, you will keep your workflows organized effortlessly. Collect, process, and verify your data all from a single interface. Easily search through both public and private databases using key characteristics of drugs. Categorize drugs and clinical trials based on comprehensive patient demographics. Retrieve necessary data in straightforward language. Strengthen your conclusions by linking your findings to their original sources. Direct your focus towards creating valuable outputs from your data, bypassing the tedious manual sorting process. Our advanced language models empower researchers to conduct asset evaluations 4.8 times quicker than traditional methods. We provide access to an extensive index of over 38 million scientific articles, conference papers, and clinical trial data. With this system, you’ll have all the information you require at your fingertips, ensuring timely and informed decision-making. Additionally, our platform adapts to your unique needs, enhancing the research experience even further.

Arterys is an innovative medical imaging AI platform that seamlessly integrates advanced AI clinical applications into your existing PACS or EHR workflows, making it an intuitive extension of your current practices. Our goal is to bring AI into the forefront by enhancing physician experiences, improving diagnostic accuracy and treatment efficacy, optimizing financial outcomes, and providing significant benefits for both patients and healthcare providers. Accessible from any validated device through the cloud, it offers rapid performance and easy deployment without the exchange of PHI, ensuring complete security. Fully connected to PACS, RIS, EMR, and dictation software, Arterys enhances your workflow without disruption. Its rapid deployment capabilities require minimal on-premise infrastructure, and it is commercially available in more than 100 countries. The platform's elastic cloud GPU architecture significantly boosts the performance of various tasks, such as rendering complex 3D files, handling large multi-dimensional datasets, and executing multiple AI applications simultaneously in real time. Additionally, features like pre-fetching and image caching contribute to quicker loading times and more efficient analysis, making it an indispensable tool in modern healthcare. This comprehensive approach positions Arterys as a leader in transforming medical imaging through artificial intelligence.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

Primarily, the nxtHealth Smart Technologies for Telehealth enhances patient care by extending the therapeutic experience beyond traditional clinical environments. The nxtHealth APPS offer continuous care through features that enable measurement, data collection, reporting, and exercise guidance directly on mobile devices. For instance, the nxtHealth WEARBLS work in tandem with the APPS by providing valuable data from wearable sensors. These APPS and WEARBLS are integrated smoothly via a HIPAA-compliant backend, which includes a provider portal equipped with advanced data ANALYTX capabilities. Additionally, nxtHealth enhances the quality of data, communication between patients and providers, and overall care quality through its user-friendly design and seamless integration. Furthermore, nxtHealth comprises a comprehensive array of smart technologies for telehealth aimed at supporting patient-reported outcomes (PRO), cognitive assessments, and rehabilitation efforts, ensuring a holistic approach to patient wellness.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Transform your healthcare experience with the revolutionary Soliton® AI, which is powered by 30,000 evidence-based rules and advanced machine learning techniques. By automating various healthcare and care management functions, Soliton® equips you with the tools necessary to thrive in a value-based care environment, offering unmatched capabilities. It efficiently analyzes vast amounts of patient data in real-time, leading to enhancements in both clinical outcomes and financial performance, while also supporting a range of Alternative Payment Models (APMs). The solution boosts the effectiveness of telehealth by forecasting billable codes during patient interactions and predicting future healthcare costs through sophisticated risk stratification models. Furthermore, it provides timely clinical decision support to assist in managing intricate patient populations. Soliton® optimizes the patient journey, facilitating seamless transitions from acute to post-acute care through AI-driven care coordination. Moreover, it identifies care gaps, uncovers service and coding opportunities, and generates tailored patient assessments and personalized care plans, while also enabling the creation of custom cohorts for targeted interventions. As a result, Soliton® not only enhances operational efficiency but also elevates the overall quality of patient care.

Envision a transformative approach to care management that lowers healthcare expenses, reduces both admissions and readmissions, enhances star ratings and HEDIS metrics, and elevates health quality and outcomes through a mission-focused data platform driven by artificial intelligence. As the healthcare sector increasingly embraces value-based care, Health EM.AI emerges as a pioneer, redefining care management and enhancing care delivery through innovative data utilization and AI technology. By streamlining patient information from various care settings and leveraging AI/ML-driven predictive analytics, we equip healthcare organizations with actionable insights that significantly enhance care quality. Our approach ensures measurable improvements at the individual patient level, particularly within palliative and chronic care management workflows. The integration of unified patient 360 data across all care settings leads to meaningful advancements in star ratings, risk adjustment, and the effective closing of care gaps. Additionally, our localized healthcare models examine over 1,000 clinical and non-clinical variables based on geographical context, further refining the effectiveness of care. This comprehensive strategy not only fosters better patient outcomes but also encourages a more efficient healthcare ecosystem.

Amazon Comprehend Medical is a natural language processing (NLP) service compliant with HIPAA that leverages machine learning to retrieve health information from medical texts without requiring any prior machine learning expertise. A significant portion of health data exists in unstructured formats such as physician notes, clinical trial documentation, and patient medical records. The traditional approach of manually extracting this data is labor-intensive and inefficient, while automated methods based on strict rules often overlook crucial contextual details, leading to incomplete data capture. Consequently, this limitation results in valuable information remaining untapped for large-scale analytical efforts that are essential for progressing the healthcare and life sciences sectors, ultimately impacting patient care and operational efficiencies. By addressing these challenges, Amazon Comprehend Medical enables healthcare professionals to harness their data more effectively for better decision-making and innovation.

Medical AI represents a groundbreaking technological advancement that effectively tackles chronic illnesses. This innovative solution is distinguished by its capabilities to forecast outcomes, recommend optimal subsequent actions, and deliver information in a user-friendly manner. DeLorean Medical AI enhances human decision-making, paving the way for a future where both machines and humans collaboratively achieve superior results. Our technology not only enhances health outcomes but is also the first AI system to receive biological validation through independent clinical evaluations. By improving the classification of patient demographics, assessing risk factors, and forecasting transitions in disease states, Medical AI plays a crucial role in the early detection and diagnosis of various health conditions. Additionally, it contributes to cost reductions within healthcare systems. With over ten clients already utilizing our solution, it has proven effective in generating savings and reducing costs through real-time analytics that identify at-risk populations and provide next-best-action suggestions grounded in statistical evidence. Furthermore, as the healthcare landscape continues to evolve, the integration of such advanced technologies will become increasingly vital in ensuring better patient care and resource management.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.

Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.

Introducing a versatile API designed to seamlessly integrate with your diabetes management system, offering tailored therapeutic education and enhanced insights into blood glucose level fluctuations. This solution enables real-time risk predictions, fostering greater personalization and improved system regulation, while adeptly managing complex living scenarios characterized by rapid glucose variations. With advancements in telemedicine and retrospective analysis, patients receive robust decision-support tools. Currently, Hillo is developing the next iterations of its AI technology, which includes a therapeutic recommendation system aimed at preventing hypoglycemia and hyperglycemia, anticipated to achieve CE mark class IIB by 2020. Additionally, a new generation of the artificial pancreas is projected for release in 2021, addressing key limitations of existing systems through ultra-personalization driven by machine learning. This innovative approach marks the introduction of the first self-learning artificial intelligence capable of predicting blood glucose levels, aiming to secure a CE mark as a medical device, thereby transforming diabetes management for users. In essence, Hillo's advancements could significantly enhance the quality of life for individuals managing diabetes.

Revolutionary AI-Driven Documentation Tool for Healthcare Professionals. Experience the cutting-edge AI solution tailored for mental health professionals across Australia. Enhance your productivity, precision, and patient results to an unprecedented level. MedReport AI is dedicated to empowering healthcare practitioners to optimize their workflows and provide superior care to a larger number of patients by harnessing the transformative capabilities of artificial intelligence. Additionally, this innovative tool is designed to adapt to the unique needs of each practitioner, ensuring customized support for a variety of clinical settings.

mPower Clinical Analytics, created by Nuance and seamlessly integrated with Microsoft’s Azure platform, is a sophisticated analytics tool aimed at optimizing radiology workflows. This solution empowers healthcare providers to derive meaningful insights from unstructured clinical data, ultimately leading to better decision-making and enhanced operational efficiency. Utilizing artificial intelligence and machine learning, mPower Clinical Analytics plays a crucial role in recognizing trends, forecasting results, and refining processes in radiology departments. As a result, it not only boosts productivity but also contributes to improved patient care outcomes.

Alife’s advanced AI software is designed to enhance clinic operations, leading to better patient outcomes, greater efficiency, and an improved overall experience for patients. The Alife Assist platform is customizable to support clinic staff in making informed decisions based on data analysis. By integrating smoothly with electronic medical records (EMR), Alife’s AI swiftly transforms raw data into practical insights. It also aims to maximize the retrieval of mature oocytes from ovarian stimulation cycles. This suite of products is created to empower all clinic personnel, ensuring that every team member can contribute effectively. Furthermore, it standardizes the embryo grading process while enhancing quality control and record management. Real-time monitoring of clinic key performance indicators (KPIs) boosts operational efficiency, saving valuable time and reducing costs. Research indicates that interpretable machine learning models perform comparably to embryologists when it comes to selecting optimal embryos for IVF transfer, showcasing their potential utility in clinical settings. Additionally, the study highlights that AI-driven insights might assist in fine-tuning the timing of ovulation trigger injections, potentially leading to improved outcomes for patients undergoing IVF treatments. Overall, this innovative approach represents a significant leap forward in reproductive health technology.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

Clario’s Image Redact AI efficiently removes sensitive patient identifiers from various media formats, including videos, photos, and PDFs. This cutting-edge solution combines AI-powered de-identification with the vigilant oversight of a skilled quality control (QC) team, ensuring compliance with EU GDPR and other privacy laws. By implementing this technology, organizations can mitigate the risk of significant penalties and potential liabilities stemming from data breaches. Each image undergoes a thorough de-identification process, leveraging our unique AI capabilities alongside comprehensive human visual QC review to confirm that all necessary redactions have been executed. Additionally, all images are securely stored across multiple geographical locations in data centers that conform to the latest security standards and practices. Users can effortlessly access and evaluate their protected videos, photos, and PDFs on any device, making it an invaluable resource for clinical trial research projects, while also enhancing overall data security and accessibility.

Enhance the effectiveness of antimicrobial use in hospitals by equipping prescribers and Antimicrobial Stewardship Program (ASP) members with our innovative AI-driven software, ZEVAC. The challenge of antibiotic resistance represents a critical public health concern today. ZEVAC is an advanced AMS software harnessing the power of AI to assist hospitals in eliminating unnecessary or improper antibiotic prescriptions. It employs a scientific yet unconventional methodology in combating the rise of antimicrobial resistance (AMR). By utilizing ZEVAC, clinicians can access precise and tailored antibiotic susceptibility predictions, which are informed by patient demographics, clinical details, local hospital prevalence, susceptibility trends, and historical culture data. In addition, ZEVAC empowers ASP members by providing proactive strategies to prevent inappropriate antimicrobial use through its real-time analysis of comprehensive hospital clinical data, ultimately fostering a more responsible approach to antibiotic stewardship. This multifaceted approach not only aids in individual patient care but also contributes to the broader goal of preserving antibiotic efficacy for future generations.

SubtlePET enhances image quality through denoising techniques, allowing scans to be completed in just a quarter of the usual time while still delivering diagnostic images that match the quality of the original ground truth images. This technology significantly boosts the effectiveness of accelerated scanning protocols. By shortening scan durations, facilities can efficiently accommodate patients, which is particularly advantageous for young children under sedation or those who struggle to remain still. Reduced scanning time not only alleviates patient discomfort and anxiety but also minimizes potential pain associated with prolonged procedures. Additionally, SubtlePET optimizes the throughput of existing PET machines by enabling hospitals and imaging centers to process more patients daily, thereby decreasing wait times and enhancing PET capacity, while simultaneously creating additional opportunities for other imaging applications, such as CT and cardiac PET. This improvement in efficiency underscores the importance of innovative technologies in modern medical imaging practices.

Microsoft Cloud for Healthcare serves as an all-encompassing platform aimed at revolutionizing the healthcare sector by utilizing AI-driven solutions, integrating data, and ensuring secure, interconnected experiences. This platform assists healthcare providers, payors, and life sciences entities in enhancing patient care, optimizing operations, and bolstering research efforts. It provides resources for protecting confidential information, streamlining clinical processes, and fostering better patient engagement. By harnessing actionable insights derived from integrated clinical and operational data, Microsoft Cloud for Healthcare empowers organizations in the healthcare field to achieve favorable results, boost efficiency, and lower expenses. Ultimately, this innovative platform is pivotal in shaping the future of healthcare delivery.

MIM Fertility is committed to improving the success rates of in vitro fertilization by leveraging artificial intelligence (AI) and data analytics. Our focus has been on creating AI solutions that empower IVF clinics to help patients realize their dreams of parenthood. We strive to redefine fertility care standards, aiming to transform the journey of infertility and ensure greater access to fertility solutions globally. Among our innovative offerings are AI-driven software platforms such as EMBRYOAID and FOLLISCAN. EMBRYOAID aids embryologists and physicians by quickly assessing the most promising embryos using images and time-lapse technology, which improves the embryo selection process for IVF. Meanwhile, FOLLISCAN serves as an ovarian follicular monitoring tool that effectively counts and measures follicles of varying sizes through 2D or 3D cine-loops of the ovaries, streamlining imaging ultrasonography workflows to boost diagnostic precision. By integrating advanced technology into fertility treatments, we believe we can significantly enhance patient experiences and outcomes.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

At Enlitic, we believe that the power of artificial intelligence can transform healthcare by enabling effective data management and improving clinical workflows. Our mission at Enlitic is to intelligently manage healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows and create a foundation for a real-world evidence medical image database for healthcare providers. Through our Enlitic Framework, we aim to reimagine healthcare intelligence, enabling healthcare professionals to make informed decisions and provide personalized care to every patient.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

Trovo assistants utilize specialized models and tailored workflows to ensure that healthcare practices can quickly adapt and thrive. Our goal is to support physicians in enhancing patient care and boosting operational efficiency. By integrating AI-driven assistants with the expertise of a multidisciplinary care team, we enable practices to broaden their horizons. Trovo Health's advanced platform, supported by skilled professionals from various fields, empowers healthcare providers to extend their services with ease. By leveraging specialized workflow technology along with the knowledge of expert team members, providers can introduce new services for patients, enhance outcomes, and streamline their operations. The company has assembled a dedicated group of clinicians and technology experts to realize its ambitious vision. With the new funding, Trovo aims to further enhance its technology platform, expand clinical operations, and strengthen its leadership team. The innovative platform developed by Trovo tackles some of the most pressing challenges faced in care delivery and operational processes, setting a new standard for healthcare solutions. Ultimately, Trovo is committed to revolutionizing healthcare services through advanced technology and collaborative care.

Introducing artificial intelligence for IVF directly at the point of care, revolutionizing the influence of extensive image and text data on business insights in reproductive medicine. We have gathered a team of the foremost specialists in artificial intelligence, IVF lab quality control/assurance, and digital technology solutions to develop this innovative platform, which boasts the largest open-source image database dedicated to embryology and andrology competency assessment globally. ART Compass emerges as the state-of-the-art IVF Lab Information Management System (LIMS), enhancing IVF lab quality management through artificial intelligence, all accessible via a user-friendly smartphone app. This platform allows for the evaluation of embryology and andrology competency assessments, as well as supports clinical decision-making in these fields. Users can also access annual procedure evaluation documentation, record new training for procedures, and onboard new staff seamlessly. Furthermore, it enables tracking of pregnancy outcomes for each IVF cycle while providing all necessary statistics. In addition, it facilitates management of patient cryostorage inventory and efficiently delivers preimplantation genetic testing results to physicians, ensuring a comprehensive approach to reproductive health. Ultimately, ART Compass is not just a tool; it represents a significant advancement in how IVF labs can operate and improve patient care.

The Bookend Healthcare AI Agent platform enhances administrative efficiency across all stages, from patient care to payment processing. By simplifying intricate prior authorization procedures, it relieves healthcare providers from labor-intensive tasks and minimizes expensive denials. Through automation, we enable an increase in operational efficiency, expedite revenue cycles, and significantly enhance patient outcomes. Our sophisticated agents evaluate patient information, interpret insurance policies, and compile essential details for precise and prompt submissions, which leads to elevated approval rates and quicker reimbursements. Additionally, our AI-driven platform transforms the healthcare landscape by streamlining the creation and implementation of tailored care plans. We assist healthcare providers in proactively recognizing evidence-based interventions that optimize patient outcomes while simultaneously lowering costs. Moreover, this platform equips clinicians with the tools to make informed decisions based on data, thereby raising the quality of care and boosting patient satisfaction levels, ultimately fostering a more effective healthcare system.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

Developed by healthcare professionals for their peers, this technology aims to significantly enhance the quality of life for patients. Our AI-driven platform emphasizes speed, scalability, and security while offering the flexibility and customization that each hospital requires. It serves as a dependable long-term resolution. With RapidAI's stroke portfolio, you can expedite triage and transfer decisions with greater precision. Additionally, it facilitates the swift identification, monitoring, and proactive management of aneurysms. RapidAI's comprehensive suite of products for pulmonary embolism care enables quick detection of suspected PE cases. The AI-enhanced clinical decision support (CDS) software accelerates the decision-making process for physicians; however, it is crucial to recognize that not all AI solutions are equal. Only those CDS tools that possess clinical expertise can accurately identify, locate, characterize, and quantify suspected conditions. This advanced level of precision in AI-powered CDS modules contributes to improved triage and transfer decisions, ultimately leading to enhanced diagnostic accuracy and more efficient vascular care. By integrating these cutting-edge tools, healthcare providers can significantly elevate patient outcomes and operational efficiency.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.

Enhance your examination capabilities from any location and boost patient outcomes with intuitive, real-time imaging that is both economical and highly portable. Introducing the groundbreaking 3rd generation portable ultrasound, which is now 30% smaller and lighter than its predecessors. The Clarius HD3 offers unparalleled portable ultrasound technology tailored for your specific specialty, featuring a user-friendly app driven by artificial intelligence and seamlessly integrated with cloud connectivity. With the Clarius HD3, you can expect crisp and clear imaging that makes it simple to pinpoint anatomy, accurately diagnose conditions, and guide procedures in real-time right at the patient's side. This innovative device is equipped with artificial intelligence, 192 piezoelectric elements, and an impressive eight beamformers, which together provide the superior performance typically associated with cart-based systems, all while maintaining the lightweight feel of a conventional probe. As we move towards a future where smart devices operate without ports, the Clarius HD3 incorporates cutting-edge antenna technology designed for the most dependable direct WiFi connection to your mobile iOS or Android devices, eliminating the need for ports or cables altogether, thus ensuring maximum convenience. This advancement represents a significant leap forward in diagnostic imaging technology.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

Our state-of-the-art technology, powered by artificial intelligence (AI), transforms both organized and disorganized healthcare information into a dependable, high-quality, standardized dataset that can be utilized throughout your organization. By facilitating near real-time access to data from various systems, our solutions alleviate the strain of manual data abstraction, enabling your administrative and clinical teams to reclaim valuable time for quality improvement and research endeavors. Our suite of products and services empowers you to gather, assess, and utilize your data effectively, irrespective of the data source, therapeutic area, organizational department, or pre-existing reporting, business intelligence, or analytics tools. Atlas leverages both human knowledge and AI capabilities to streamline the challenging process of uncovering and interpreting patient data for clinical registries. Meanwhile, Cartographer efficiently searches, evaluates, and interprets patient data across multiple platforms, standardizes that information into a uniform format, and offers pertinent data insights. Ultimately, our innovative solutions not only enhance operational efficiency but also support informed decision-making throughout your organization.

EVIDENS is an advanced AI platform that facilitates the discovery of digital cohorts, enhances research capabilities, promotes collaboration, and enables the sharing of insights across extensive hospital data sets. With the ability to swiftly annotate and convert your data into AI-compatible formats, users can efficiently filter populations by various clinical outcomes or demographic factors. The platform allows for limitless keyword filtering by training AI models to perform targeted searches. Furthermore, users can explore and establish criteria for cohort identification with the support of intelligent AI tools. Training AI models to automate the analysis process and categorize data into distinct groups can be done quickly and efficiently. The platform outputs AI-ready cohorts to facilitate the testing of clinical hypotheses in research studies. Users can effortlessly monitor the status and tasks related to all their projects and collaborators, while also being able to observe and engage with activities aligned with their research interests. Additionally, collaborative tools are provided to enable simultaneous efforts in creating, training, and validating AI models, fostering a productive research environment. Ultimately, EVIDENS streamlines the entire research process, making it more efficient and effective for all involved.

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

Microsoft's Dragon Copilot represents a sophisticated AI-powered tool aimed at optimizing clinical processes through the automation of documentation, thereby alleviating administrative pressures. By seamlessly integrating with the Microsoft Cloud for Healthcare, it assists healthcare professionals in efficiently generating precise documentation based on interactions between patients and clinicians. This innovative solution accommodates various languages and retains functionality without internet access, enabling the collection of patient information and its transformation into notes tailored to specific medical specialties. Additionally, Dragon Copilot harnesses AI technology to propose enhancements for clinical interactions, automatically completes orders, and enables clinicians to search through notes and retrieve medical data, ultimately enhancing both operational efficiency and the quality of patient care. With its ability to adapt to the needs of healthcare providers, Dragon Copilot is poised to significantly revolutionize the way clinical documentation is handled.

Clinithink stands out as a premier technology firm in the healthcare sector, focusing on artificial intelligence solutions that convert unstructured medical information into valuable insights. The company's proprietary CLiX platform leverages Clinical Natural Language Processing (CNLP) to decipher intricate clinical narratives, which empowers healthcare providers to improve both patient outcomes and operational productivity. Clinithink delivers customized solutions across various domains, including life sciences, revenue cycle management, and population health, effectively tackling issues such as identifying patient cohorts, maximizing reimbursement, and monitoring disease progression. With its cutting-edge technology, Clinithink has earned the confidence of top pharmaceutical and healthcare entities globally, establishing its leadership in the realm of healthcare AI and digital health progress. Moreover, the CLiX platform is adept at comprehending a wide array of unique and intricate clinical concepts, including but not limited to certainty, severity, laterality, and temporality, further enhancing its utility in clinical settings. As the demand for innovative healthcare solutions grows, Clinithink remains committed to advancing its technology to meet the evolving needs of the industry.

NVIDIA® Parabricks® stands out as the sole suite of genomic analysis applications that harnesses GPU acceleration to provide rapid and precise genome and exome analysis for various stakeholders, including sequencing centers, clinical teams, genomics researchers, and developers of high-throughput sequencing instruments. This innovative platform offers GPU-optimized versions of commonly utilized tools by computational biologists and bioinformaticians, leading to notably improved runtimes, enhanced workflow scalability, and reduced computing expenses. Spanning from FastQ files to Variant Call Format (VCF), NVIDIA Parabricks significantly boosts performance across diverse hardware setups featuring NVIDIA A100 Tensor Core GPUs. Researchers in genomics can benefit from accelerated processing throughout their entire analysis workflows, which includes stages such as alignment, sorting, and variant calling. With the deployment of additional GPUs, users can observe nearly linear scaling in computational speed when compared to traditional CPU-only systems, achieving acceleration rates of up to 107X. This remarkable efficiency makes NVIDIA Parabricks an essential tool for anyone involved in genomic analysis.

Our healthcare enablement platform significantly reduces the administrative burden on clinicians, leading to enhanced experiences for patients. By streamlining the process of connecting patients to the appropriate care swiftly, we can increase patient volumes effectively. This system minimizes the time clinicians spend on non-clinical tasks, alleviating frustration and burnout by automating various administrative responsibilities. Additionally, we create a cohesive and integrated technological environment that complements your current EMR system. With the power of conversational AI and intelligent adaptive interviews, Fabric brings together virtual and in-person healthcare services seamlessly, covering all aspects from intake to treatment while automating staff workflows. Developed based on clinical guidelines by a dedicated team of healthcare professionals, Fabric’s clinical intelligence engine ensures high standards of care quality, while also providing patients with omnichannel access to services. This approach not only enhances operational efficiency but also fosters better patient outcomes and satisfaction.